CDSCO monthly lab alert
CDSCO NSQ alert, December 2024: 135 drug batches flagged
By Blacklisted editorial team· Published 20 Jan 2025· Updated 3 Nov 2026· Source: CDSCO NSQ portal
In its December 2024 alert, the Central Drugs Standard Control Organisation listed 135 drug batches that failed quality tests, 51 at central laboratories and 84 at state drug-testing laboratories, from 109 manufacturers across 112 products. The most common failure was dissolution, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Metoprolol Succinate Prolonged Release Tablets IP, Rabeprazole Injection IP, Povidone- Iodine Ointment USP.
135
Batches flagged
51 / 84
Central / state labs
Dissolution
Top reason
109
Manufacturers
Batches per month, last 12 alerts
Jan 2024Dec 2024 · 135
Full list of NSQ batches, December 2024
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Zinc Sulphate Dispersible Tablets IP 20 mg | Batch LMT240811Mfg Jul 2024 · Exp Jun 2026 | Life Max Cancer Laboratories | Uniformity of dispersion & DisintegrationDisintegration | RDTL GuwahatiCDSCO lab |
| ZINC SULPHATE DISPERSIBLE TABLETS IP 20mg (CARE ZINC) | Batch TH241106Mfg Aug 2024 · Exp Jul 2026 | Orchid MedlifePvt. ltdHimachal Pradesh | On the received sample chipping and rough surface defects were observed, which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(V) and (VII) respectivelyOther | PuducherryState lab |
| Vithrocin Suspension, Azithromycin Oral Suspension | Batch AZ/L/01/40 09Mfg Aug 2024 · Exp Jul 2026 | Vital Therapeutics & Formulations Pvt.LtdTelangana | As sample failed with respect to test in pH as per IP further product is MISBRANDEDpH | State Lab Drugs Control Laboratory, TelanganaState lab |
| Valsartan Tablets IP 80mg(Valsalar- 80 Tablets) | Batch VSR1-05Mfg Apr 2024 · Exp Mar 2026 | Lark Laboratories (India) LtdRajasthan | The Sample does not conform to IP Standards with respect to Test for Dissolution onlyDissolution | CDTL ChennaiCDSCO lab |
| Trubery LS | Batch Z-23388Mfg Sep 2023 · Exp Aug 2025 | CSD LifesciencesHimachal Pradesh | Sample does not conform to Label with respect to the content of Levosalbutamol in Levosalbutamol sulphate.Labelling | DTL ChennaiState lab |
| Tranexamic Acid Tablets IP 500 mg (Clip 500) | Batch 054A003Mfg Jan 2024 · Exp Dec 2025 | FDC Limited L-56 & L-57Goa | Related SubstancesRelated substances | CDL KolkataCDSCO lab |
| Thyroxine Sodium tablets IP (THYROX-25) | Batch 16240148DMfg May 2024 · Exp Apr 2026 | Macleods Pharmaceuticals LtdGujarat | DissolutionDissolution | CDL KolkataCDSCO lab |
| Terbicharge 250 mg (TerbinafineHyd rochloride Tablets IP) | Batch NT-4303Mfg Jun 2023 · Exp May 2025 | Neptune Life Sciences Pvt. LtdHimachal Pradesh | Test for Dissolution onlyDissolution | State Lab KarnatakaState lab |
| Telmisartan Tablets I.P.. (TELMOPI-40) | Batch 23I-T2003Mfg Dec 2023 · Exp Nov 2025 | Orison Pharma InternationalHimachal Pradesh | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Tamcof-Ls Syrup | Batch AGL23022 1CMfg Mar 2024 · Exp Feb 2026 | Asterisk Healthcare | Sample does not conform to Label claim with respect to the content of Ambroxol HydrochlorideLabelling | DTL ChennaiState lab |
| Surgi Spirit | Batch SS-084032Mfg Aug 2024 · Exp Jul 2026 | Transflex | Sample does not conform IP Specifciation for Surgical Spirit with respect to weight per ml.Weight | DTL ChennaiState lab |
| Sucrazum-O Suspension | Batch ALL-899Mfg Aug 2023 · Exp Jul 2025 | Access Life ScienceHimachal Pradesh | Sample does not conform to Label claim with respect to the content of Oxetacaine.Labelling | DTL ChennaiState lab |
| Snikuf 4 | Batch RZAB01Mfg May 2023 · Exp Apr 2025 | Akums Drugs & Pharmaceuticals LtdUttarakhand | Sample does not conform to label claim with respect to the content of Terbutaline Sulphate.Labelling | DTL ChennaiState lab |
| Sertraline Hydrochloride (USP/ EP) | Batch SER240002B FPMfg May 2024 · Exp Apr 2025 | Exemep PharmaceuticalsGujarat | "Related substances"Related substances | CDTL MumbaiCDSCO lab |
| Rosuvastatin, Aspirin & Clopidogrel Capsules (20mg/75mg/75 mg) | Batch MC240184Mfg Feb 2024 · Exp Jan 2026 | Mascot Health Series Pvt. LtdUttarakhand | Sample does not conform to Label claim with respect to the content of Aspirin and to Schedule V of Drugs and Cosmetics Act, with respect to free Salicylic Acid.Labelling | DTL ChennaiState lab |
| Retrazith-250 | Batch WT3927FMfg Mar 2024 · Exp Feb 2026 | Saphnix Life SciencesHimachal Pradesh | Sample does not conform to IP specification for Azithromycin Tablets with respect to Dissolution and to the Content of Anhydrous Azithromycin Dihydrate.Dissolution | DTL ChennaiState lab |
| Ranitidine Hydrochloride Injection I.P | Batch AV3082Mfg Feb 2023 · Exp Jan 2025 | Alpa Laboratories LtdMadhya Pradesh | Test for SterilitySterility | State Lab KarnatakaState lab |
| Ramipril & Metoprolol Succinate Tablets (Ramigan -MT 2.5/ 25 Tablets) | Batch AOT23322Mfg Jun 2023 · Exp May 2025 | Astonea Labs Pvt. LtdHaryana | "Assay of Ramipril"Assay | CDTL MumbaiCDSCO lab |
| Rabeprazole Sodium Injection IP | Batch MD23H20Mfg Aug 2023 · Exp Jul 2025 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | pH, Water, Clarity of Solution, Particulate matter, Assay of Rabeprazole Sodium and DescriptionAssay | CDL KolkataCDSCO lab |
| Rabeprazole Injection IP | Batch AGI-23216Mfg Jun 2023 · Exp May 2025 | Alliaance BiotechHimachal Pradesh | Sterility, Clarity of Solution, Particulate matter, Identification, Assay of Rabeprazole Sodium and Description?. The sample is deemed to be spurious as per section 17B of Drugs and Cosmetics ActAssay | CDL KolkataCDSCO lab |
| Rabeprazole Injection IP | Batch AGI-23217Mfg Jun 2023 · Exp May 2025 | Alliaance BiotechHimachal Pradesh | pH, Clarity of Solution, Particulate matter, Assay of Rabeprazole Sodium and DescriptionAssay | CDL KolkataCDSCO lab |
| Rabeprazole Gastro-resistant Tablets IP 20 mg (Robijick - 20) | Batch T- 1047Mfg Jun 2023 · Exp May 2025 | Jackson Laboratories Pvt. LtdPunjab | "Dissolution (Acid stage) & (Buffer stage) and Description"Dissolution | CDTL MumbaiCDSCO lab |
| Povidone- Iodine Ointment USP | Batch VG24025Mfg Apr 2024 · Exp Mar 2026 | Microwin Labs PVt LtdPunjab | Sample does not conform to USP Spcification for povidine-IODINE Ointment with respect to the content of Avaible Iodine in povidone Iodine.Other | DTL MaduraiState lab |
| Povidone- Iodine Ointment USP | Batch VG23017Mfg Nov 2023 · Exp Oct 2025 | Microwin Labs PVt LtdPunjab | Sample does not conform to USP Specification for Povidone - Iodine Ointment with respect to the content of Avaible Iodine in Povidone Iodine.Other | DTL MaduraiState lab |
| Peedon | Batch P2409Mfg May 2024 · Exp Apr 2026 | Sharing formulations Pvt LtdGujarat | Sample does not conform to label claim with respect to the content of Available Iodine in Povidone-Iodine.Labelling | DTL ChennaiState lab |
| Paracetamol Tablets IP 650 mg | Batch PCT24135Mfg Jun 2024 · Exp May 2026 | VivekPharmachem (India) LtdRajasthan | Test for DissolutionDissolution | State Lab KarnatakaState lab |
| Paracetamol Tab IP 500 mg. | Batch D2370/24- 25Mfg ? · Exp ? | Kerala Medical Services Corporation LtdKerala | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab |
| Paracetamol Paediatric Oral Suspension IP (MYPAR) | Batch S404115Mfg Apr 2024 · Exp Mar 2026 | ION Healthcare Pvt. LtdHimachal Pradesh | "Related substances"Related substances | CDTL MumbaiCDSCO lab |
| Pantoprazole Sodium Tabletes IP 40mg | Batch P01824Mfg Aug 2024 · Exp Jul 2026 | Spansules formulation India Pvt LtdTelangana | The sample Does not comply in respect of Dissolution Test as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Pantoprazole Gastro-resistant and Domperidone Prolonged- release Capsules IP (Unipraz - DSR) | Batch UC-23001CMfg Jul 2023 · Exp Jun 2025 | Ultra Drugs Pvt. LtdHimachal Pradesh | "Dissolution of Domperidone"Dissolution | CDTL MumbaiCDSCO lab |
| Pantacea 40 Tablets and Pantoprazole Gastro Resistant Tablets IP 40mg | Batch PNTC3007Mfg Nov 2023 · Exp Oct 2025 | Windlas Biotech Limited Plant-2Uttarakhand | The sample Does not complies in respect of Dissolution Test as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Panik-D Tablets (Pantoprazole Sodium &Domperidone Tablets) | Batch KPT24K08 AMfg Feb 2024 · Exp Jan 2026 | Kaizen PharmaceuticalsHimachal Pradesh | test for DisintegrationDisintegration | State Lab KarnatakaState lab |
| PRIMAQUINE PHOSPHATE TABLETS IP 2.5 mg | Batch T-1338Mfg Jul 2023 · Exp Jun 2025 | Jackson Laboratories Pvt. LtdPunjab | Dissolution and AssayAssay | RDTL GuwahatiCDSCO lab |
| PANTOPRAZOL E GASTRO- RESISTANT TABLETS IP 40mg (PANTIN) | Batch GT24502AMfg Jun 2024 · Exp May 2027 | Hetero Healthcare LimitedAssam | Dissolution of Buffer StageDissolution | RDTL GuwahatiCDSCO lab |
| PANTOPRAZO LE GASTRO- RESISTANT TABLETS IP 40mg (Pentowok) | Batch WAM2401 1Mfg May 2024 · Exp Apr 2026 | Admed Pharma Pvt. Ltd | Does not comply with respect to the Disintegration test as per IP specificationDisintegration | PuducherryState lab |
| Orsiclop-A75 | Batch NTT24103 6Mfg Mar 2024 · Exp Feb 2026 | Nanoceut Therapeutics Pvt. LtdPuducherry | Sample does not conform to IP specification for Clopidogrel and Aspirin Tablets with respect to Dissolution (Clopidogrel and Aspirin), Free Salicylic Acid (Related substance for Aspirin) and to the content of ASpirinDissolution | DTL ChennaiState lab |
| Ondansetron Tablets IP 4 mg | Batch 320D2401Mfg Apr 2024 · Exp Mar 2026 | SSM Formulations Private Limited | Sample does not conform to IP Specification for Ondansetron Tablets with respect to Dissolution.Dissolution | DTL ChennaiState lab |
| Ondansetron Injection IP-2ml | Batch A24AM130Mfg Apr 2024 · Exp Mar 2026 | Skymap Pharamceuticals Pvt. LtdUttarakhand | sample does not conform to requirement for assay and related substancesAssay | King Institute ChennaiState lab |
| Omeprazole Lyophilized Powder for Injection (I.V) (OMERA 40mg Lyophilized Powder for Injection) | Batch 0ZI2415ACMfg Jun 2024 · Exp May 2026 | Celon Laboratories Pvt. LtdTelangana | Test of Water by KFWater content | CDL KolkataCDSCO lab |
| Octenidine Dihydrochlordie Gel | Batch PPKAC84Mfg May 2023 · Exp Apr 2026 | Pure & Cure Healthcare Pvt. LtdUttarakhand | Sample does not conform to label claim with respect to the content of Octenidine Dihydrochloride.Labelling | DTL MaduraiState lab |
| O Mak-200 | Batch VMWT240 7Mfg Jun 2024 · Exp Mar 2026 | Vertex Pharma Chemicals | Sample does not conform to IP Specification of Ofloxacin Tablets with respect to the content of Ofloxacin.Other | DTL MaduraiState lab |
| Nutrisacc Bolus | Batch MVNUR2403Mfg Feb 2024 · Exp Feb 2026 | Maven iLab Pvt.LtdKarnataka | Disintegration test and Assay of Iron, Magnesium, Calcium, Vitamin B3,Zinc and Vitamin AAssay | RDTL ChandigarhCDSCO lab |
| Noscapine, Chlorpheniramine Maleate, Guaiphenesin & Sodium Citrate Syrup | Batch NGC-091Mfg Dec 2023 · Exp Nov 2025 | Medipol Pharmaceutical India Pvt. LtdHimachal Pradesh | DescriptionDescription | CDL KolkataCDSCO lab |
| Metoprolol Succinate Prolonged Release Tablets IP | Batch URDT0654Mfg Mar 2023 · Exp Feb 2025 | Unicure India LtdUttarakhand | It fails the test ?Assay? as per IP standards [Amendment List - 05 to IP 2022]Assay | DTL ThiruvananthapuramState lab |
| Metoprolol Succinate Prolonged Release Tablets IP | Batch URDT0653Mfg Mar 2023 · Exp Feb 2025 | Unicure India LtdUttarakhand | It fails the test ?Assay? as per IP standards [Amendment List - 05 to IP 2022]Assay | DTL ThiruvananthapuramState lab |
| Metoprolol Succinate Prolonged Release Tablets IP | Batch URDT0652Mfg Mar 2023 · Exp Feb 2025 | Unicure India LtdUttarakhand | It fails the test ?Assay? as per IP standards [Amendment List - 05 to IP 2022]Assay | DTL ThiruvananthapuramState lab |
| Metoheal XL 25 (Metoprolol Succinate Extended release Tablets U.S.P) | Batch T24D800AMfg Apr 2024 · Exp Mar 2026 | Bajaj FormulationUttarakhand | Test for Dissolution? & content of Metoprolol Succinate in the AssayAssay | State Lab KarnatakaState lab |
| Metoclopramide HCL Injection I.P-2ml | Batch 24DQC64Mfg Mar 2024 · Exp Feb 2026 | SVP Life SciencesUttarakhand | sample does not conform to the requirement for Assay of MetoclopramideAssay | King Institute ChennaiState lab |
| Metoclopramide HCL Injection I.P-2ml | Batch HLI405DMfg Apr 2024 · Exp Mar 2026 | Himalaya Meditek Pvt. LtdUttarakhand | sample does not conform to the requirement for Assay of MetoclopramideAssay | King Institute ChennaiState lab |
| Metformin Hydrochloride Sustained Release Tab IP 500 mg | Batch D2164/24-25Mfg ? · Exp ? | Kerala Medical Services Corporation LtdKerala | It fails the test microbial contamination in Non-sterile products and Descriptive part for tablets as per IPMicrobial limits | DTL ThiruvananthapuramState lab |
| Meropenem Injection IP 500 mg (Merohuge 500) | Batch A4ITX004Mfg Aug 2024 · Exp Jul 2026 | Shamshree Lifesciences LimitedHimachal Pradesh | Test of Clarity of solution, Particulate matterParticulate matter | CDL KolkataCDSCO lab |
| Megapure-TZ IU suspension | Batch 23L-162Mfg Sep 2023 · Exp Aug 2025 | Prispag Pharma | Sample does not conform to label claim with respect to the content of Ciprofloxacin in Ciprofloxacin Hydrochloride and Tinidazole.Labelling | DTL ChennaiState lab |
| METFORMIN TABLETS IP 500 mg (GLYCIPHAGE) | Batch G0374057Mfg Jun 2024 · Exp May 2027 | Franco-Indian Pharmaceuticals Pvt LtdMaharashtra | Does not comply with respect to the Assay as per IP specificationAssay | PuducherryState lab |
| METFORMIN HYDROCHLOR IDE TABLETS IP (OKAMET- 500) | Batch 4O30069Mfg Feb 2024 · Exp Jan 2027 | Cipla LtdHimachal Pradesh | Does not comply with respect to the Assay as per IP specificationAssay | PuducherryState lab |
| Losartan Potassium Tablets IP 50 mg | Batch HLOA09Mfg Nov 2023 · Exp Oct 2025 | Hindusthan Antibiotics LtdHaryana | It fails the test ?Dissolution? as per IP as specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab |
| Lignocaine Hydrochloride Gel IP 5% w/v (30 g) | Batch G406Mfg Sep 2024 · Exp Aug 2026 | Gnosis Pharmaceuticals Pvt. LtdHimachal Pradesh | pHpH | CDL KolkataCDSCO lab |
| Levocetirizin Hydrochloride &Montelukast Sodium Tablets IP (Montefirst- LC) | Batch 2405097Mfg May 2024 · Exp Apr 2026 | Aban PharmaceuticalsKerala | Test for Dissolution of Levocetirizine Hydrochloride and MontelukastDissolution | State Lab KarnatakaState lab |
| Justkof-LS | Batch UF267408 2FMfg Jan 2024 · Exp Dec 2025 | Ultra Drugs Formultations Pvt LtdHimachal Pradesh | sample does not conform to Label claim with respect to the content of Ambroxol Hydrochloride.Labelling | DTL MaduraiState lab |
| Jikcf-AZ Tablets, Cefixime and Azitromycin Tablets | Batch BPT-3001Mfg Feb 2024 · Exp Jan 2026 | Geenac PharmaUttarakhand | The sample does not meets the Specifications with respect to Identification test-Nil Assay-Nil As per STP u/s. 17B of Drugs and Cosmetics Act 1940. The Sample deemed to be SPURIOUS.Assay | State Lab Drugs Control Laboratory, TelanganaState lab |
| Jikcef-LB Tablets, Cefixime and Lactic Acid Bacillus Tablets | Batch BPT-3005Mfg Feb 2024 · Exp Jan 2026 | GeenacPharmaUttarakhand | The sample does not meets the Specifications with respect to Identification test-Nil Assay-Nil As per STP u/s. 17B of Drugs and Cosmetics Act 1940. The Sample deemed to be SPURIOUS.Assay | State Lab Drugs Control Laboratory, TelanganaState lab |
| Jakclav-625 Tablets, Amoxicillin and Potassium Clavulanate Tablets | Batch BPT-3002Mfg Feb 2024 · Exp Jan 2026 | Geenac PharmaUttarakhand | The sample Does not meet the Specifications wrt. Identification test - Negative, Assay- Nil As per IP u/s. 17B of Drugs and Cosmetics Act 1940. the Sample deemed to be SPURIOUS and Misbranded.Assay | State Lab Drugs Control Laboratory, TelanganaState lab |
| Iron Sucrose Injection USP- 5ML | Batch PGY23118Mfg Aug 2023 · Exp Jul 2025 | Affy ParenteralsHimachal Pradesh | Sample does not conform to requirement for assay for iron.Assay | King Institute ChennaiState lab |
| ITRACHARGE 200 (Itraconazole Capsules BP) | Batch NC-0805Mfg Jun 2023 · Exp May 2025 | Neptune Life Sciences Pvt. LtdHimachal Pradesh | Dissolution Test onlyDissolution | State Lab KarnatakaState lab |
| INFUSION SET- NV (INFUSION SET - NV) | Batch KT-033Mfg Mar 2024 · Exp Feb 2027 | Medivision HealthcareGujarat | SterilitySterility | RDTL GuwahatiCDSCO lab |
| Hydroxychloroqui ne Sulphate Tableta IP 200 mg (QUEENJAJ 200) | Batch HCQ19K23Mfg Nov 2023 · Exp Oct 2026 | Bajaj Healthcare LtdGujarat | "Related substances"Related substances | CDTL MumbaiCDSCO lab |
| Glimepiride Tablets IP 1mg | Batch PGG24- 002Mfg Jun 2024 · Exp May 2026 | Pondchy PharmaceuticalsPuducherry | Sample does not conform to IP specification for Glimepiride Tablets with respect to Dissolution.Dissolution | DTL ChennaiState lab |
| Glimepiride Tablets I.P. 1 mg | Batch LMT240339Mfg Mar 2024 · Exp Feb 2026 | Life Max Cancer Laboratories | Dissolution of GlimepirideDissolution | RDTL GuwahatiCDSCO lab |
| Gabacure Gel | Batch HUAA46Mfg Jun 2024 · Exp Nov 2025 | Akums Druges & Pharmaceuticals Ltd. 47Uttarakhand | Sample does not conform to Label claim with respect to the content of Gobapentin.Labelling | DTL MaduraiState lab |
| GLIMEPIRIDE TABLETS IP (GLIMP-1) | Batch SPT240261Mfg Feb 2024 · Exp Jan 2026 | Salus PharmaceuticalsHimachal Pradesh | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Flucent Pour-on Solution | Batch PB-105/12Mfg Dec 2023 · Exp Nov 2025 | Indo Gulf Pharmaceuticals | Sample does not conform to Label claim with respect to Identification and Content of Flumethrin.Identification | DTL MaduraiState lab |
| Fexofenadine Hydrochloride Tablets IP (MANOFEX-180) | Batch CT24250327 AMfg May 2024 · Exp Apr 2026 | CMG Biotech Pvt. Ltd | DissolutionDissolution | CDL KolkataCDSCO lab |
| Fercobate-XT Suspension (Ferrous Ascorbate& Folic acid Suspension) | Batch 240603Mfg Jun 2024 · Exp Nov 2025 | ShinestarPharma | Folic Acid in the Assay and MisbrandedAssay | State Lab KarnatakaState lab |
| Esilac Soluion | Batch ZBL-1154Mfg Dec 2023 · Exp Nov 2025 | Zoic Biotech Pvt .LtdPunjab | Sample does not conform to USP Specification for Lactulose Solution with respect to the Content of Lactulose in Lactulose Concentrate.Other | DTL ChennaiState lab |
| Duloxetine Gastro-resistant Tablets IP 20 mg | Batch T26904Mfg Jan 2024 · Exp Dec 2025 | Quest Laboratories Pvt. LtdMadhya Pradesh | Description and DissolutionDissolution | RDTL ChandigarhCDSCO lab |
| Divalproex Extended Release Tablets IP (JKMSCL Hospital Supply not for sale) | Batch 2406031Mfg Jun 2024 · Exp May 2026 | Biodeal Pharmaceuticals Pvt. LtdHimachal Pradesh | Uniformity of WeightsUniformity of weight/content | DTL Srinagar (J&K) & MDTL Kathua (J&K)State lab |
| Divalproex Extended Release Tablets IP (JKMSCL Hospital Supply not for sale) | Batch 2407185Mfg Jul 2024 · Exp Jun 2026 | Biodeal Pharmaceuticals Pvt. LtdHimachal Pradesh | Uniformity of WeightsUniformity of weight/content | DTL Srinagar (J&K)State lab |
| Diphenhydramine Hydrochloride, Ammonium Chloride, Sodium Citrate & Menthol Syrup (Beedryl Plus) | Batch 40183Mfg Feb 2024 · Exp Jan 2026 | Zenith Drugs Ltd. 72/5 & 72/3Madhya Pradesh | Assay of Menthol and DescriptionAssay | CDL KolkataCDSCO lab |
| Diphenhydramine Hydrochloride, Ammonium Chloride, Sodium Citrate & Menthol Syrup (Beedryl Plus) | Batch 40186Mfg Feb 2024 · Exp Jan 2026 | Zenith Drugs Ltd. 72/5 & 72/3Madhya Pradesh | Assay of Menthol and DescriptionAssay | CDL KolkataCDSCO lab |
| Dexamethasone Tablets IP 0.5mg | Batch TA24036Mfg Jan 2024 · Exp Dec 2025 | Saintlife Pharmaceuticals LtdUttarakhand | Sample does not conform to IP Specification for Dexamethasone Tablets with respect to the content of Dexamethasone.Other | DTL ChennaiState lab |
| Dexamethasone Tablets IP 0.5mg | Batch TA24035Mfg Jan 2024 · Exp Dec 2025 | Saintlife Pharmaceuticals LtdUttarakhand | Sample does not conform to IP Specification for Dexamethasone Tablets with respect to the content of Dexamthasone.Other | DTL ChennaiState lab |
| Dexamethasone Sodium Phosphate Injection I.P. | Batch 119Mfg Jun 2024 · Exp May 2026 | Hindustan Medicines Pvt. Ltd | Free Dexamethasone, Particulate matter, Sterility, Extractable volume and DescriptionDescription | CDL KolkataCDSCO lab |
| Dexamethasone Injection IP-2ml | Batch FDDTI-004Mfg Feb 2024 · Exp Jan 2026 | Laborate Pharmaceuticals India LtdHimachal Pradesh | Sample does not conform to requirement for Assay.Assay | King Institute ChennaiState lab |
| DOXYCYCLINE CAPSULES IP 100 mg | Batch HDXA08Mfg Jun 2023 · Exp May 2025 | Hindustan Antibiotics LtdHaryana | "Uniformity of weight"Uniformity of weight/content | CDTL MumbaiCDSCO lab |
| DEXTROMETH ORPHAN HYDROBROMI DE PHENYLEPHRI NE HYDROCHLOR IDE & CHLORPHENIR AMINE MALEATE TABLETS (Expal) | Batch AST- 23303Mfg Aug 2023 · Exp Jul 2025 | AASSK Pharmaceuticals Pvt. LtdTamil Nadu | On visual inspection dark spots are found on tablet surface.Cappingand lamination defects are found. Some tablets were brittle on opening from the strip - NSQOther | PuducherryState lab |
| Compound Sodium Lactate Injection I.P. 500 ml (Ringers Lactate I.P.) (RL) | Batch 03BF2474Mfg Apr 2024 · Exp Mar 2027 | Paschim Banga Pharmaceuticals | SterilitySterility | RDTL GuwahatiCDSCO lab |
| Compound Sodium Lactate Injection I.P. (RL) | Batch 03BF2472Mfg Apr 2024 · Exp Mar 2027 | Paschim Banga Pharmaceuticals | Sterility and Particulate ContaminationSterility | RDTL GuwahatiCDSCO lab |
| Cold Plus Syrup (Cold Plus Syrup) | Batch 4EL02283Mfg Sep 2024 · Exp Aug 2027 | Ciron Drugs & Pharmaceuticals Pvt. LtdMaharashtra | Assay of Phenylephrine HydrochlorideAssay | CDL KolkataCDSCO lab |
| Co-Trimoxazole Tablets IP 480mg | Batch MT404Mfg Jan 2024 · Exp Dec 2026 | Maxwell Lifescience Pvt LtdMaharashtra | Sample does not conform to IP Specification for Co- Trimoxazole Tablets with respect to Dissolution for SulphamethoxazoleDissolution | DTL ChennaiState lab |
| Co- trimoxazole Tablets I.P. (D.S.=Double Strength) | Batch PT30119Mfg May 2023 · Exp Apr 2025 | Omega PharmaUttarakhand | Dissolution (Trimethoprim and Sulphamethoxazo le)Dissolution | RDTL GuwahatiCDSCO lab |
| Clobium Suspension. Clobazam Oral Suspension BP 5mg | Batch TYOL-047Mfg Jul 2024 · Exp Jun 2026 | Tanmed Pharma (I) Pvt LtdTamil Nadu | Sample does not conform to BP specification for Clobazam Oral Suspension with respect to Dissolution and to the content of ClobazamDissolution | DTL ChennaiState lab |
| Ciprofloxacin Hydrochloride Tablets IP 500mg | Batch HTN1126LMfg Nov 2023 · Exp Oct 2025 | Himalaya Meditek Pvt. LtdUttarakhand | Sample does not conform to IP specification for ciprofloxacin tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Cipladine Ointment | Batch CHO40020Mfg Jan 2024 · Exp Dec 2025 | HSN InternationalUttarakhand | Sample does not conform to USP Specification for Povidone-Iodine Ointment with respect to the content of Avaible Iodine in Povidone Iodine.Other | DTL MaduraiState lab |
| Cipladine Multipurpose Antiseptic Skin Ointment | Batch CH040103Mfg Mar 2024 · Exp Feb 2026 | HSN InternationalUttarakhand | Sample does not conform to USP specification for povidone-Iodine Ointment with respect to content of available Iodine in povidone Iodine.Other | DTL ChennaiState lab |
| Cipladine | Batch CHO40018Mfg Jan 2024 · Exp Dec 2025 | HSN InternationalUttarakhand | Sample does not conform to USP Specification for Povidone- Iodine Ointment with respect to the content of Avaible Iodine in Povidone Iodine,Other | DTL MaduraiState lab |
| Cipex-500 (Ciprofloxacin Tabets I.P) | Batch MUTAD23 01Mfg Jun 2023 · Exp May 2026 | Maxtar Bio-GenicsHimachal Pradesh | Test for Dissolution onlyDissolution | State Lab KarnatakaState lab |
| Chro-B Gold | Batch DCBGT- 2402Mfg Sep 2024 · Exp Feb 2026 | Kniss Laboratories (P) LtdTamil Nadu | Sample does not conform to label claim with respect to the content of CholecalciferolLabelling | DTL ChennaiState lab |
| Chlorpheniramin e Maleate Injection | Batch IAL77/23Mfg Dec 2023 · Exp Nov 2025 | Anra Pharamaceuticals Pvt Ltd | Sample does not conform to the requirement for Assay for ChlorpheniramineAssay | King Institute ChennaiState lab |
| CefpodoximePr oxetil Dispersible Tablets (Qupod- 200 Tablets) | Batch KCT- 403002Mfg Mar 2024 · Exp Feb 2026 | Knox Life SciencesHimachal Pradesh | Test for Uniformity of DispersionUniformity of weight/content | State Lab KarnatakaState lab |
| Cefpodoxime Tablets IP 200 mg (Jan Aushadhi) | Batch CT3096Mfg Sep 2023 · Exp Aug 2025 | Bharat Parenterals LtdGujarat | Assay of CefpodoximeAssay | CFDL Jammu (J&K)State lab |
| Cefotaxime Sodium Injection IP 1 g | Batch DP24029Mfg Apr 2024 · Exp Mar 2026 | Bengal Chemicals & Pharmaceuticals LtdWest Bengal | Test of Clarity of solution, Particulate matterParticulate matter | CDL KolkataCDSCO lab |
| Ceaxil -500 Tablets, Cefuroxime Axetil Tablets IP | Batch BT-227375Mfg Jan 2024 · Exp Dec 2025 | Dr. Edwin Medilabs Pvt.LtdPunjab | White coloured, elongated, biconvex tablets with score on one side, and plain on other side, 10 out of 50 tablets have brown- coloured spots on the entire surface. Hence, the tablets failed the test for Description of tablets.Description | State Lab Drugs Control Laboratory, TelanganaState lab |
| Capiwash Mouthwah | Batch FL-050BMfg Aug 2023 · Exp Jul 2025 | Forgo PharmaceuticalsHimachal Pradesh | Sample does not conform to IP Specification for Chlorhexidine Mouthwash IP with respect to the content of Chlorhexidine Gluconate in Chlorhexidine Gluconate Solution.Other | DTL MaduraiState lab |
| Calcium with Vitamin D3 Tablets (CITCAL TABLETS) | Batch 470823Mfg Aug 2023 · Exp Jul 2025 | Uniplus Biotech (P) Ltd | Dissolution (calcium) and Assay of Vitamin D3Assay | RDTL GuwahatiCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (Calcovit D3 Tablets) | Batch MWT2311 80Mfg Jan 2024 · Exp Dec 2025 | MedworPharmaHimachal Pradesh | Test for Dissolution for Calcium, Assay for Vitamin D3? and with respect to ?DescriptionAssay | State Lab KarnatakaState lab |
| Calcium 500 mg with Vitamin D3 250 IU Tablets IP | Batch LMT240346Mfg Mar 2024 · Exp Feb 2026 | Life Max Cancer LaboratoriesUttarakhand | Assay of Vitamin D3 and Dissolution for calciumAssay | RDTL GuwahatiCDSCO lab |
| Calcium & Vitamin D3 Tablets IP (CALCI-D) | Batch CDD23089Mfg Nov 2023 · Exp Oct 2025 | Danish Health Care (P) Ltd | Assay of Vitamin D3Assay | RDTL GuwahatiCDSCO lab |
| Cadcof-Lx Syrup | Batch DLS2378Mfg Jun 2024 · Exp May 2026 | Dhwanilife Care Pvt LtdGujarat | Sample does not conform to Label Claim with respect to the content of Levosalbutamol in Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin.Labelling | DTL ChennaiState lab |
| CIPRODAC 500 (Ciprofloxacin Tablets IP 500mg) | Batch AN24014Mfg Jan 2024 · Exp Dec 2026 | Cadila Pharmaceuticals LimitedGujarat | The Sample does not conform to standard in respect of the test "Dissolution" performedDissolution | SDTL Agartala, TripuraState lab |
| CEFIXIME AND LACTIC ACID BACILLUS TABLETS (CFI- 200) | Batch T925Mfg Sep 2023 · Exp Aug 2025 | Swiss Biotech ParentralsHaryana | On the received sample presence of spots/discoloration observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discolorationDescription | PuducherryState lab |
| Bupivacaine Hydrochloride in Dextrose Injection USP 4 ml | Batch 17B24005Mfg Sep 2024 · Exp Aug 2026 | Radiant Parenterals LtdGujarat | pH and Bacterial EndotoxinspH | CDL KolkataCDSCO lab |
| Bupivacaine Hydrochloride in Dextrose Injection USP 4 ml | Batch 17B24004Mfg Jun 2024 · Exp May 2026 | Radiant Parenterals LtdGujarat | pH, Bacterial Endotoxins and SterilitySterility | CDL KolkataCDSCO lab |
| Brokuf-DM | Batch CBL- 0024/24Mfg Feb 2024 · Exp Jan 2026 | C.B. HealthcareHimachal Pradesh | Sample does not conform to Label claim with respect to the content of phenylephrine Hydrochloride.Labelling | DTL ChennaiState lab |
| Bortezomib Injection IP (BORTEWIN 2 mg Injection) | Batch L24BZ08A7Mfg Aug 2024 · Exp Jul 2026 | Medion Biotech Pvt. LtdHimachal Pradesh | Assay of BortezomibAssay | RDTL ChandigarhCDSCO lab |
| Betamethasone Valerate Ointment IP 01% w/w | Batch B06Mfg May 2024 · Exp Apr 2026 | Syndicate PharmaMadhya Pradesh | Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone Valerate.Other | DTL MaduraiState lab |
| Balarishtam | Batch 107Mfg Sep 2024 · Exp Sep 2034 | Alappat Pharma | It fails the test Total Solids and Specific Gravity as per APIOther | DTL ThiruvananthapuramState lab |
| BUPIVACAINE HYDROCHLORI DE INJECTION IP 0.5% | Batch BCV22315Mfg Dec 2023 · Exp Nov 2025 | Nandani Medical Laboratories Pvt. LtdMadhya Pradesh | Particulate mattter and DescriptionDescription | CDL KolkataCDSCO lab |
| BETAHISTINE DIHYDROCHL ORIDE TABLETS IP (CGHEST-8) | Batch CT242502 84BMfg May 2024 · Exp Apr 2026 | CMG BIOTECH PVT. LTS (Unit-II) | On the received sample presence of spots were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discolourationDescription | PuducherryState lab |
| Atovaris-F | Batch DEMT- 240124BMfg Apr 2024 · Exp Mar 2026 | Dr. Edwin Medilabs Pvt.Ltd | Sample does not conform to IP Specification with respect to Uniformity of Weight.Uniformity of weight/content | DTL MaduraiState lab |
| Atorvastatin Tablets IP 10mg | Batch A283Mfg Apr 2024 · Exp Mar 2026 | Rikenbik PharmaTamil Nadu | Sample does not conform to IP Specification for Atorvastatin Calcium Tablets with respect to Dissolution.Dissolution | DTL ChennaiState lab |
| Atorvastatin Calcium Tablets IP 10mg | Batch HTN414DMfg Apr 2024 · Exp Mar 2026 | Himalaya Meditek Pvt. LtdUttarakhand | Sample does not conform to IP Specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Atorvastatin Calcium Tablets IP 10mg | Batch HTN405DMfg Apr 2024 · Exp Mar 2026 | Himalaya Meditek Pvt. LtdUttarakhand | Sample does not conform to IP Specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Aspirin Gastro- resistant Tablets IP 75mg | Batch ANET1121Mfg Aug 2023 · Exp Jul 2025 | Unicure India LtdUttar Pradesh | Test of Dissolution Buffer StageDissolution | CDL KolkataCDSCO lab |
| Amoxymoon CV-625 [Amoxycillin and Potassium Clavulanate Tablets IP] | Batch VT 241704Mfg Oct 2024 · Exp Mar 2026 | VADSP PharmaceuticalsHimachal Pradesh | It fails the tests ?Assay? and ?Dissolution? for Clavulanic Acid as per IP, as specified in the Laboratory Protocol.Assay | DTL ThiruvananthapuramState lab |
| Amoxycillin Dispersible Tablets IP 125 mg | Batch PGA24- 002Mfg Mar 2024 · Exp Feb 2026 | Pondchy PharmaceuticalsPuducherry | Sample does not conform to IP Specification for Dispersible Tablets with respect to uniformity of Dispersion and DisintegrationDisintegration | DTL ChennaiState lab |
| Amlod-At | Batch DT240289Mfg Feb 2024 · Exp Jan 2026 | Daeiou Pharmaceutical (P) LtdPuducherry | Sample does not conform to IP Specification for Amlodipine and Atenolol Tablets with respect to Dissolution for Amlodipine and to the Content of Amlodipine in Amlodipine in Amlidipine Besylate.Dissolution | DTL ChennaiState lab |
| Amitriptyline Tablets IP 25mg | Batch TA24159Mfg Apr 2024 · Exp Mar 2026 | Saintlife Pharmaceuticals LtdUttarakhand | Sample does not conform to IP specification for tablets with respect to Definition.Other | DTL ChennaiState lab |
| Amikacin Sulphate Injection I.P. (AmikaVen- 500 Injection) | Batch L-24A-23IMfg Jan 2024 · Exp Dec 2025 | Inmac Laboratories | Particulate mattter, Assay/content of Amikacin and DescriptionAssay | CDL KolkataCDSCO lab |
| Aluminium, Magnesium &Simethicone Oral Suspension I.P | Batch C21A133003Mfg Jun 2023 · Exp May 2026 | Concept Pharmaceuticals Ltd | Description onlyDescription | State Lab KarnatakaState lab |
| Alprazolam Tablets IP 0.5 mg | Batch BT1224Mfg Jan 2024 · Exp Dec 2025 | Brilliant Life Sciences Pvt. LtdGujarat | The Sample does not conform to IP Standards with respect to Test for Dissolution onlyDissolution | CDTL ChennaiCDSCO lab |
| Albendazole Tablets I.P. | Batch MT-24G01Mfg Jul 2024 · Exp Jun 2026 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Acyclovir Dispersible Tablets IP (Zovibact 800 mg) | Batch SRTH230874 BMfg Aug 2023 · Exp Jul 2025 | Systole Remedies Pvt. LtdHimachal Pradesh | Uniformity of dispersion & DisintegrationDisintegration | RDTL GuwahatiCDSCO lab |
| Absorbent Cotton Wool IP | Batch 331Mfg Jul 2024 · Exp Jun 2026 | Vandana Surgi Pharma (P) Ltd | Acidity or alkalinity, Absorbency Sinking Time, Absorbency Water-holding Capacity, Foreign Fibres, Fluorescence, Water soluble substances, Neps and Sulphated ashWater content | CDL KolkataCDSCO lab |
| AXBEX Suspension (Multivitamin Mulltimineral & Antioxidant Suspension) | Batch A21410Mfg May 2024 · Exp Oct 2025 | Ozone Pharmaceuticals LtdHimachal Pradesh | Identification & Assay of CholecalciferolAssay | CDL KolkataCDSCO lab |
| AXBEX Suspension (Multivitamin Mulltimineral & Antioxidant Suspension) | Batch A21411Mfg May 2024 · Exp Oct 2025 | Ozone Pharmaceuticals LtdHimachal Pradesh | Identification & Assay of CholecalciferolAssay | CDL KolkataCDSCO lab |
| AMIKACIN SULPHATE INJECTION IP 250 mg (AMIKACIN SULPHATE INJECTION IP 250 mg/ 2 ml for IM/IV Injection) | Batch 17800124Mfg Jan 2024 · Exp Dec 2025 | Karnataka Antibiotics & Pharmaceuticals LtdKarnataka | Particulate mattter and DescriptionDescription | CDL KolkataCDSCO lab |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Sources
- Regulator
- Regulator
Changelog
- 3 Nov 2026: table generated from the CDSCO NSQ portal export (135 rows). Revised CDSCO lists are diffed on each monthly rebuild.